Top Banner
Kuhlmann et al. Suppl. Figure SUVH2 (At2g33290) SUVH9 (At4g13460)
8

Kuhlmann et al. Suppl. Figure 1. Kuhlmann et al. Suppl. Figure 2 SRA-domainSET-domain Gabi-Kat_516A07 SALK_079574 At2g33290 SUVH2 SRA-domainSET-domain.

Mar 27, 2015

Download

Documents

Katherine Pratt
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Kuhlmann et al. Suppl. Figure 1. Kuhlmann et al. Suppl. Figure 2 SRA-domainSET-domain Gabi-Kat_516A07 SALK_079574 At2g33290 SUVH2 SRA-domainSET-domain.

Kuhlmann et al. Suppl. Figure 1

SUVH2 (At2g33290) SUVH9 (At4g13460)

Page 2: Kuhlmann et al. Suppl. Figure 1. Kuhlmann et al. Suppl. Figure 2 SRA-domainSET-domain Gabi-Kat_516A07 SALK_079574 At2g33290 SUVH2 SRA-domainSET-domain.

Kuhlmann et al. Suppl. Figure 2

SRA-domain SET-domain

Gabi-Kat_516A07SALK_079574

At2g33290 SUVH2

SRA-domain SET-domainAt4g13460 SUVH9

SALK_048033

SALK_048093

LB-p1::SUL1-p35S> RB RB <p35S-SUL1::P1-LB

Gabi-Kat_516A07

TGAACGGCAA 1937bp 1946bp CTGCAACTAGpAC161

pAC161

Page 3: Kuhlmann et al. Suppl. Figure 1. Kuhlmann et al. Suppl. Figure 2 SRA-domainSET-domain Gabi-Kat_516A07 SALK_079574 At2g33290 SUVH2 SRA-domainSET-domain.

Kuhlmann et al. Suppl. Figure 3

rel. mRNA SUVH2 / mRNA PFK

0,001

0,01

0,1

1

Col suvh2 suvh9 suvh2/suvh9

rel. mRNA SUVH9 / mRNA PFK

0,00001

0,0001

0,001

0,01

0,1

1

Col suvh2 suvh9 suvh2/suvh9

rel mRNA act2 /mRNA PFK

0,1

1

10

100

Col suvh2 suvh9 suvh2/suvh9

SUVH2 / PFK rel. RNA

SUVH9 / PFK rel. RNA

ACT2 / PFK rel. RNA

wt suvh2 suvh9 suvh2 suvh9

wt suvh2 suvh9 suvh2 suvh9

wt suvh2 suvh9 suvh2 suvh9

A

B

C

mRNA of seedlings rel. to PFK mRNA (median with min and max deviation)

0,00001

0,0001

0,001

0,01

0,1

1

10

100

Col suvh2 suvh9 suvh2/suvh9

SUVH2

SUVH9

act2

mRNA of imbibed seeds rel. to act2 (median with min and max deviation)

0,00001

0,0001

0,001

0,01

0,1

1

Col suvh2 suvh9 suvh2/suvh9

D

E

wt suvh2 suvh9 suvh2 suvh9

wt suvh2 suvh9 suvh2 suvh9

Page 4: Kuhlmann et al. Suppl. Figure 1. Kuhlmann et al. Suppl. Figure 2 SRA-domainSET-domain Gabi-Kat_516A07 SALK_079574 At2g33290 SUVH2 SRA-domainSET-domain.

Kuhlmann et al. Suppl. Figure 5

0

10

20

30

40

50

60

70

80

90

100

Col-0 mycSUVH2

% m

eth

yla

tion

Wt Pro35S-mycSUVH2 leaves leaves

A 100

90

80

70

60

50

40

30

20

10

0

0

10

20

30

40

50

60

70

80

90

100

Col-0 Col-0 seedlings myc-SUVH2

% m

eth

ylat

ion

Complete CG CNG CNN

% m

eth

yla

tion

Wt Wt Pro35S-mycSUVH2 leaves seedlings leaves

B100

90

80

70

60

50

40

30

20

10

0

total C CG CHG CHH

Page 5: Kuhlmann et al. Suppl. Figure 1. Kuhlmann et al. Suppl. Figure 2 SRA-domainSET-domain Gabi-Kat_516A07 SALK_079574 At2g33290 SUVH2 SRA-domainSET-domain.

Kuhlmann et al. Suppl. Figure 6

24mer -

wt

suvh

2 s

uvh9

wt

suvh

2 s

uvh9

AtSN1 (A)

tRNA

EtBr

Page 6: Kuhlmann et al. Suppl. Figure 1. Kuhlmann et al. Suppl. Figure 2 SRA-domainSET-domain Gabi-Kat_516A07 SALK_079574 At2g33290 SUVH2 SRA-domainSET-domain.

Kuhlmann et al. Suppl. Figure 7

A B

C D

total C CG CHG CHH

Page 7: Kuhlmann et al. Suppl. Figure 1. Kuhlmann et al. Suppl. Figure 2 SRA-domainSET-domain Gabi-Kat_516A07 SALK_079574 At2g33290 SUVH2 SRA-domainSET-domain.

PCR SUVH2

PCR SUVH9

PCR PFK

PCR ACT2

Kuhlmann et al. Suppl. Figure 8

Page 8: Kuhlmann et al. Suppl. Figure 1. Kuhlmann et al. Suppl. Figure 2 SRA-domainSET-domain Gabi-Kat_516A07 SALK_079574 At2g33290 SUVH2 SRA-domainSET-domain.

Suppl. Table: Sequences of used primesPrimers used for genotyping:suvh2:SUVH2-gaby-F: ATATGCAGGTGTAGTTGTCACGAGSUVH2-gaby-R: ATGGCGAGCTTGCCGTTCACTTCT-DNA-insertion pAC161: pAC161 5´-out: ATATTGACCATCATACTCATTGCpAC161-F (NOS): GATGTCCGCAGCGTTATTATAAAATGPAC161-R (NOS): CGCATAATCTCAGACCAATCTGAsuvh9:SUVH9-SALK-F: ATGGGTTCTTCTCACATTCCTCTTGSUVH9-SALK-R: CAGTGATCCTCACTAGCTCCGACGT-DNA-insertion pROK2:pROK2 3´-out: GAAATATTTGCTAGCTGATAGTGpROK2-F (pNOS): GAGCGGAGAATTAAGGGAGpROK2-R (pNOS): GAGAACCTGCGTGCAATC

Primers used for qPCR:At4g04040 (Phospfofructokinase, Kapoor et al., 2005):F (B8F): gccacgaaaaccaaacagacR (B8R): ccggaatttcgatcaatcct At3g18780 (Actin-2 An et al., 1996):F: tgagagattcagatgcccagaaR: ttgattccagcagcttccatAt2g33290 (SUVH2):F: atatgcaggtgtagttgtcacgagR: atggcgagcttgccgttcacttcAt4g13460 (SUVH9):F: atgggttcttctcacattcctcttR: cagtgatcctcactagctccgacgAtSN1-A (AtSN1- Fragment A):F (F4) aaaataagtggtggttgtacaagcR (ATS15): accaacgtgctgttggcccagtggtaaatcAtSN1-B (AtSN1- Fragment B):F (A205): tgagagatttaccactgggccaacaR (A206): tgaggagctcaacacataaatggcaataAtSN1-C (AtSN1- Fragment C):F (A207): cctttccaagacaccatctcaacaacR (A208): tcctcaacaaaaataattccgaacgac

Primers used for converted target regions: AtSN1 (chromosome III, nucleotides 15,805,617–15,805,773) :AtSN1-bi-F: caatatacratccaaaaaacarttattaaaataatatcttaa (JP 1821, Johnson et al., 2008)AtSN1-bi-R: gttgtataagtttagttttaattttayggatyagtattaattt (JP 1822, Johnson et al., 2008)AtCopia4:AtCopia4-bi-F: ggttgtytgtgttttttatggttyagattttata (JP 3100, Johnson et al., 2008)AtCopia4-bi-R: ataactraaccacarattcaracccattttcattt (JP 3101, Johnson et al., 2008)

Primers used for quantitative amplification of genomic regions after ChIP:At4g04040 (Phospfofructokinase, beta-subunit, Mathieu et al., 2003):F: gccacgaaaaccaaacagacR: ccggaatttcgatcaatcct At3g18780 (Actin-2 An et al., 1996):F: tgagagattcagatgcccagaaR: ttgattccagcagcttccatTa3-LTR (Johnson et al., 2002):F (JP1617): tagggttcttagttgatcttgtattgagctcR  (JP1618): tttgctctcaaactctcaattgaagtttAtSN1-A (AtSN1- Fragment A, Herr et al., 2005):F (F4) aaaataagtggtggttgtacaagcR (ATS15): accaacgtgctgttggcccagtggtaaatcAtSN1-B (AtSN1- Fragment B):F (A205): tgagagatttaccactgggccaacaR (A206): tgaggagctcaacacataaatggcaataAtSN1-C (AtSN1- Fragment C):F (A207): cctttccaagacaccatctcaacaacR (A208): tcctcaacaaaaataattccgaacgac

Kuhlmann et al. Suppl. Table